Monarch Biosciences
Latest round
- Seed
Last raised
- Apr 2020
Total raised
- $1M
Investors
- 1
About Monarch Biosciences
Monarch Biosciences Inc.Monarch Biosciences Inc. specializes in developing medical devices that leverage Thin Film Nitinol technology. The company is based in Los Angeles, US. It was founded by Colin Kealey, who has a history in the healthcare sector.Monarch Biosciences specializes in the commercialization of advanced medical device and biotechnology products that leverage Thin Film Nitinol technology. This innovative approach enables the development of devices that exhibit superior performance characteristics, including enhanced flexibility, strength, and durability, making them suitable for a range of medical applications. The company focuses on addressing critical healthcare challenges, such as improving patient outcomes in minimally invasive procedures. Their client base includes hospitals, surgical centers, and healthcare providers across North America and Europe, who utilize these products to deliver treatment options to patients.Monarch Biosciences generates revenue predominantly through direct sales of its flagship medical devices to healthcare institutions. The company employs a B2B transaction structure, where products are sold directly to hospitals and clinics, ensuring that these institutions have access to the latest in medical technology. Revenue streams are supported by long-term partnerships and agreements with healthcare providers, enabling integrated solutions that enhance clinical outcomes. Pricing structures for their advanced devices reflect the value delivered in terms of improved patient care and operational efficiency, although specific pricing details remain undisclosed.Monarch Biosciences is working on the development of new medical devices that utilize advanced materials and technologies, aiming for launches in the upcoming years. The company plans to expand into European markets, targeting specific regions with high healthcare demands by 2022.
Who invested in Monarch Biosciences
1 investor across 1 round
See all investors in Monarch Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Apr 6, 2020
Amount
$1M
Investors
Questions about Monarch Biosciences
Who invested in Monarch Biosciences?
Monarch Biosciences has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Monarch Biosciences raised?
Monarch Biosciences has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Monarch Biosciences last raise money?
Monarch Biosciences's most recent round on record is a Seed, in Apr 2020.
What does Monarch Biosciences do?
Monarch Biosciences is a biotechnology company.
Where is Monarch Biosciences headquartered?
Monarch Biosciences is headquartered in Los Angeles, US.
Which VCs invest in companies like Monarch Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Monarch Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Monarch Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.